George Zogopoulos

7PUBLICATIONS

82CO-AUTHORS

Predictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 26, 2026

Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinoma.

|Jul 02, 2025

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Jennifer J Knox, Gun Ho Jang, Robert C Grant

|Apr 04, 2025

The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.

Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue

|Aug 09, 2023

Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.

Joan Miguel Romero, Emma Titmuss, Yifan Wang

|Jun 01, 2023

Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.

Bryson W Katona, Kelsey Klute, Randall E Brand

|Oct 12, 2022

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.

Sheron Perera, Gun Ho Jang, Yifan Wang

Pageof 2

Frequent Collaborators

Yifan Wang

Jennifer J Knox

Faiyaz Notta

Julie Wilson

Grainne M O'Kane

Ravi Ramjeesingh

Marco Marra

Joan Miguel Romero

Steven Gallinger

Mustapha Tehfe

Frequent Collaborators

Yifan Wang

Jennifer J Knox

Faiyaz Notta

Julie Wilson